Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Gene therapy R&D roadmap – tools and techniques

18 Nov 2019
An author's perspective General interest

This In the Zone infographic explores the tools and techniques used during the AAV gene therapy development pathway, detailing the neccessary steps during the process; from rAAV generation and in vitro and in vivo testing through to assessing the host immune response.

 


 

itz-gene-therapy-banner

Top content

  • Newborns and people with Alzheimer’s share a surprising biomarker
  • A pivotal peril of profoundly pernickety peptides
  • Mastering bioanalytical project management

Related tags

Absorption Systems gene therapy in the zone techniques tools
Previous article Next article

Related articles

14 OCT 2024 CELL AND GENE THERAPIES
Spotlight survey: bioanalytical support for AAV therapies
6 SEP 2019 GENERAL INTEREST
In the Zone: Peptide Bioanalysis Sample Preparation
4 SEP 2023 AUTOMATION
eBook: analytical methods for viral vector development and manufacturing in gene therapy
10 APR 2019 ADVANCED THERAPIES
Cell and gene therapy infographic
13 JUL 2023 NEWS
FDA approved: the first hemophilia A gene therapy authorized for the United States
26 FEB 2019 JOURNAL ARTICLES
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 – LBA/cell-based assays: immunogenicity, biomarkers and PK assays)
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone